Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Carnitine Supplementation as a Therapy to Improve Insulin Sensitivity in Type 2 Diabetic Patients With Low Carnitine Status

NCT03230812 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT03230812
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03230812 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Carnitine Supplementation as a Therapy to Improve Insulin Sensitivity in Type 2 Diabetic Patients With Low Carnitine Status
Lead sponsor
Maastricht University Medical Center
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2018
Completion date
November 11, 2019
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glucose intolerance